Skip to main content
Clinical Trials/JPRN-UMIN000024004
JPRN-UMIN000024004
Recruiting
Phase 2

Phase II clinical trial of surgical intervention following chemotherapy for synchronous and metachronous liver metastasis from gastric cancer.(HiSCO 06) - Phase II clinical trial of surgical intervention for liver metastasis from gastric cancer.(HiSCO 06)

Hiroshima Surgical Study group of Clinical Oncology (HiSCO)0 sites30 target enrollmentSeptember 11, 2016

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Patients with synchronous or metachronous liver metastasis from gastric cancer
Sponsor
Hiroshima Surgical Study group of Clinical Oncology (HiSCO)
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 11, 2016
End Date
December 31, 2026
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hiroshima Surgical Study group of Clinical Oncology (HiSCO)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Stage IV gastric cancer patients with peritoneal dissemination, or positive cytology para aolta LN netastasis. Patients whom doctors consider unsuitable

Outcomes

Primary Outcomes

Not specified

Similar Trials